VPS34支链泛素化对自噬的调控控制着蛋白质稳态和肝脏代谢。

IF 2.6 Q3 ONCOLOGY

Molecular and Cellular Oncology Pub Date : 2021-05-05 eCollection Date: 2021-01-01 DOI:10.1080/23723556.2021.1915076

Yu-Hsuan Chen, Ruey-Hwa Chen

引用次数: 0

摘要

泛素-蛋白酶体系统和自噬是两个主要的循环过程。我们最近的工作发现了磷脂酰肌醇3-激酶催化亚基3 (PI3KC3，最广为人知的是VPS34)上的K29/K48支链泛素化。这种泛素化在病理生理条件下受到正或负调节，影响自噬、蛋白质平衡和脂质稳态。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Regulation of autophagy by VPS34 branched ubiquitination controls proteostasis and liver metabolism.

Ubiquitin-proteasome system and autophagy are the two major recycling processes. Our recent work uncovers a K29/K48 branched ubiquitination on the phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3KC3, best known as VPS34). This ubiquitination is positively or negatively regulated under pathophysiological conditions to influence on autophagy, proteostasis and lipid homeostasis.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Molecular and Cellular Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research

CiteScore

3.20

自引率

0.00%

发文量

期刊介绍： For a long time, solid neoplasms have been viewed as relatively homogeneous entities composed for the most part of malignant cells. It is now clear that tumors are highly heterogeneous structures that evolve in the context of intimate interactions between cancer cells and endothelial, stromal as well as immune cells. During the past few years, experimental and clinical oncologists have witnessed several conceptual transitions of this type. Molecular and Cellular Oncology (MCO) emerges within this conceptual framework as a high-profile forum for the publication of fundamental, translational and clinical research on cancer. The scope of MCO is broad. Submissions dealing with all aspects of oncogenesis, tumor progression and response to therapy will be welcome, irrespective of whether they focus on solid or hematological neoplasms. MCO has gathered leading scientists with expertise in multiple areas of cancer research and other fields of investigation to constitute a large, interdisciplinary, Editorial Board that will ensure the quality of articles accepted for publication. MCO will publish Original Research Articles, Brief Reports, Reviews, Short Reviews, Commentaries, Author Views (auto-commentaries) and Meeting Reports dealing with all aspects of cancer research.